Earlier this year, Tandem Diabetes Care announced a voluntary correction for certain t:slim X2 insulin pumps after identifying a potential defect that could interrupt insulin delivery and pose health ...

Experts weigh in on the most promising AI applications, from diabetic retinopathy screening to smarter insulin delivery, and ...

Although teplizumab doesn’t work for everyone and how much it delays progression varies, it has inspired new directions in ...

Living with type 1 diabetes today is leaps and bounds easier than it was decades ago. Things are only getting better ...

A little more than a century ago a diagnosis of type 1 diabetes was a death sentence. Today, thanks to extraordinary ...

The acceptance comes after a study done by the American Diabetes Association in June found that inhaled insulin is safe and ...

Can one molecule replace separate insulin and glucagon shots in Type 1 diabetes? New research shows it might be possible.

Haley Ticer, a teacher at Cape Central Middle School, shares how she learned to manage her diabetes diagnosis throughout ...

The FDA has accepted for review the sBLA for Afrezza (insulin human) inhalation powder in children and adolescents with type 1 or 2 diabetes.

The FDA has accepted MannKind's supplemental biologics license application (sBLA) for Afrezza (insulin human inhalation ...

A new gene therapy approach aimed at protecting people with type 1 diabetes from developing diabetic kidney disease — a serious and common complication of the condition, has shown promising results in ...